The budget aims to achieve financial sustainability and enhance the Emirate's economic competitiveness. The 2023 budget is a budget for development and the development of government services in the Emirate of Sharjah

o Sharjah budget 2023 with expenditures of (32.2) billion dirhams, a decrease of (12%) from the 2022 budget.

o Salaries account for (28%) of the general budget.

o (35%) of the general budget for the infrastructure and capital projects sector in the Emirate.

o (34%) of the general budget for the economic development sector focused on development processes and economic competitiveness.

o (23%) of the general budget for the social development sector, in support of scientific, cultural and heritage services, stimulation of creativity, innovation and scientific research, ensuring an ideal healthy environment and promoting decent living.

o The budget reflected the interest of His Highness, the Ruler of Sharjah, in providing ... Read more »

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new exclusive licensing and commercialization agreement with Junshi Biosciences, an innovation-driven biopharmaceutical company, for toripalimab in the Middle East and North Africa (MENA). Under the terms of the agreement, Hikma has an exclusive license to develop and commercialize toripalimab injection in all its MENA markets. In addition, Hikma has the right of first negotiation for the future commercialization of three under development drugs in MENA.

Toripalimab is an innovative anti-PD-1 monoclonal antibody approved for marketing in China for six indications to date. Over thirty toripalimab clinical studies covering more than fifteen indications have been conducted globally, including in China, the United States, Southeast Asia, and Europe. Ongoing or completed pivotal clinical studies evaluating the safety and efficacy of toripalimab cover a broad range of tumor types includi ... Read more »